Analytical Method Development - Drug Formulation
Chief Operating Officer
Velesco Pharmaceutical Services
Velesco Pharmaceutical Services honored as a 2010 "Michigan 50 Companies to Watch" and receives a "Catalyst Award" for creating 2009 economic growth
(Plymouth and Kalamazoo, MI; April 14, 2010) - Velesco Pharmaceutical Services, a contract research organization in the pharmaceutical drug development industry, has been recognized as one of the 2010 "Michigan 50 Companies to Watch," an awards program sponsored by the Edward Lowe Foundation. Additionally, Southwest Michigan First recognized Velesco with a "Catalyst Award" for creating jobs and economic success in the Kalamazoo Region in 2009.
Velesco Pharmaceutical Services was founded by pharmaceutical industry veterans and offers a full range of early drug development services including drug formulation, analytical method development/validation, cGMP clinical supplies as well as consulting.
"We are honored to have been chosen as one of the Michigan 50 Companies to Watch this year and to be recognized with a Catalyst Award for our success in 2009," says David Barnes, CEO and co-founder of Velesco Pharmaceutical Services. "Our clients count on us to deliver consistent high quality services and we are fortunate to be operating in a region with a concentration of experienced pharmaceutical researchers. This talent has fueled the growth of our company leading to a significant expansion of our client base."
In 2009, Velesco opened a cGMP clinical supply manufacturing facility in Kalamazoo and moved its development laboratories to expanded space in the Michigan Life Science and Innovation Center in Plymouth, MI.
"The second-stage businesses that comprise the Michigan 50 Companies to Watch have not only persevered through challenging times, but also found opportunities to grow," says Penny Lewandowski, director of entrepreneurship development at the Edward Lowe Foundation. "They continue to hire and develop new markets for their products and services and are making a substantial difference in their communities — and their industries."
About Velesco Pharmaceutical Services
Velesco Pharmaceutical Services (www.velescopharma.com) was formed in 2007 by former pharmaceutical R&D colleagues and focuses on supporting early stage drug development. Velesco’s founders, analytical chemists and drug formulation experts are pharmaceutical industry veterans working in a high-quality former Pfizer) facility. Velesco delivers on time high quality products and services along with insightful consultation.
# # #
News and Events
Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services
Read the Press Release!
Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.
Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.
Roundtable: M&A trends in CDMO - Molecule to Market
New Velesco Pharma clinical manufacturing facility begins operations.
Read the press release here.
Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.
Read the interview here.
Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.
Read the press release here.
CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!
1 new job postings! Careers
Velesco's work published
Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.